Tsutomu Hirano
Ebina, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Cross-Sectional Association of Lipoprotein(a) Levels With Vascular Complications and Related Parameters in a Japanese Type 2 Diabetes Cohort.
Journal: Journal of atherosclerosis and thrombosis
Published: May 20, 2026
Small Dense Low-Density Lipoprotein Cholesterol Predicts Long-Term Coronary Artery Disease Recurrence in Patients Without Metabolic Dyslipidemia.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: April 20, 2026
Pemafibrate Increases Circulating Angiopoietin-like Proteins 3 and 4 Without Promoting Pro-Atherogenic Changes in LDL and HDL Subspecies: A Post-Hoc Analysis of the PRESTIGE Study.
Journal: Journal of atherosclerosis and thrombosis
Published: October 05, 2025
Calculated Excess-Triglyceride Based on the Friedewald Formula is a Possible Surrogate Marker for the Production of Large Very-Low Density Lipoprotein, A Post-Hoc Analysis of the PROUD48 Study.
Journal: Journal of atherosclerosis and thrombosis
Published: September 18, 2025
Residual Risk for Carotid Atherosclerosis Within Normal LDL-C Levels.
Journal: JACC. Asia
Published: June 09, 2025
Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes.
Journal: Journal of diabetes investigation
Published: November 21, 2024
Excess Triglycerides in Very Low-Density Lipoprotein (VLDL) Estimated from VLDL-Cholesterol could be a Useful Biomarker of Metabolic Dysfunction Associated Steatotic Liver Disease in Patients with Type 2 Diabetes.
Journal: Journal of atherosclerosis and thrombosis
Published: September 04, 2024
Impact of Direct Measurement of Small Dense Low-Density Lipoprotein Cholesterol for Long-Term Secondary Prevention in Patients with Stable Coronary Artery Disease.
Journal: Clinical chemistry
Published: October 10, 2023
Managing hypertriglyceridemia for cardiovascular disease prevention: Lessons from the PROMINENT trial.
Journal: European journal of clinical investigation
Published: October 10, 2023
Specific Increase in Small Dense Low-Density Lipoprotein-Cholesterol Levels beyond Triglycerides in Patients with Diabetes: Implications for Cardiovascular Risk of MAFLD.
Journal: Journal of atherosclerosis and thrombosis
Published: July 12, 2023
Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy.
Journal: Journal of diabetes investigation
Published: June 19, 2023
Hypertriglyceridemia contributes significantly to high prevalence of small dense LDL-cholesterol in patients with type 2 diabetes, even when LDL-C targets are achieved.
Journal: Diabetology international
Published: February 15, 2023
Last Updated: 09/26/2026